Global Cord Blood (NYSE:CO) Coverage Initiated at StockNews.com

Analysts at StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO) in a research report issued to clients and investors on Friday. The brokerage set a “strong-buy” rating on the medical research company’s stock.

Global Cord Blood Stock Performance

Global Cord Blood stock opened at $1.75 on Friday. The company has a market capitalization of $212.71 million, a price-to-earnings ratio of 2.73 and a beta of 0.16. Global Cord Blood has a fifty-two week low of $2.03 and a fifty-two week high of $5.50. The stock has a fifty day moving average of $1.51 and a two-hundred day moving average of $1.35.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.